An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy

Assistant settings

journal：Molecular Cancer Therapeutics

Authors：Jantine E. Bakema; Marijke Stigter-van Walsum; Jeffrey R. Harris; Sonja H. Ganzevles; Anantharaman Muthuswamy; Mischa Houtkamp; Theo S. Plantinga; Elisabeth Bloemena; Ruud H. Brakenhoff; Esther C.W. Breij; Rieneke van de Ven

Published date：2024-2-1

DOI：10.1158/1535-7163.mct-23-0298

PDF link：https://aacrjournals.org/mct/art ... 557/mct-23-0298.pdf

Article link：http://dx.doi.org/10.1158/1535-7163.mct-23-0298

Article Source：American Association for Cancer Research (AACR)。


Remark：

This post has been completed

Completed attachments will be deleted within 24 hours.